A bibliometric analysis of 540 English-language AI and bone-metastasis publications through June 2026 found rapid growth ...
A 2026 review finds that miRNA nanocarriers may help overcome delivery barriers in osteosarcoma, while emphasizing unresolved ...
Onvansertib is also being evaluated in multiple other cancers through investigator-initiated studies, including metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results